Donadio Jamie A
Sr. VP, CFO at Mirati Therapeutics, Inc.
- Sold, on record
- $3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 16, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Mirati Therapeutics, Inc.Sr. VP, CFO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
4
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale Mirati Therapeutics, Inc.UnusualMar 1, 2018 2018
Sold 51,875 shares at $27.13 ($1.4M)
Donadio Jamie A, Sr. VP, CFO
Sold 100% of holdings ($1.4M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Mirati Therapeutics, Inc.UnusualMar 9, 2018 +8 days
Sold 12,100 shares at $35.00 ($424k)
Donadio Jamie A, Sr. VP, CFO
Sold 100% of holdings ($424k position)0 shares leftFiling
- 3 Form 4 sale Mirati Therapeutics, Inc.UnusualFeb 15, 2019 +343 days
Sold 7,500 shares at $75.00 ($563k)
Donadio Jamie A, Sr. VP, CFO
Sold 97.1% of holdings ($579k position)221 shares leftFiling
- 4 Form 4 sale Mirati Therapeutics, Inc.UnusualMay 16, 2019 +90 days
Sold 7,500 shares at $75.00 ($563k)
Donadio Jamie A, Sr. VP, CFO
Sold 97.1% of holdings ($579k position)221 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2019 | May 20, 2019 | Mirati Therapeutics, Inc. | Sr. VP, CFO | Form 4 sale | 7,500 | $563k | 97.1% | Unusual | SEC |
| Feb 15, 2019 | Feb 19, 2019 | Mirati Therapeutics, Inc. | Sr. VP, CFO | Form 4 sale | 7,500 | $563k | 97.1% | Unusual | SEC |
| Mar 9, 2018 | Mar 13, 2018 | Mirati Therapeutics, Inc. | Sr. VP, CFO | Form 4 sale | 12,100 | $424k | 100.0% | Unusual | SEC |
| Mar 1, 2018 | Mar 2, 2018 | Mirati Therapeutics, Inc. | Sr. VP, CFO | Form 4 sale | 51,875 | $1.4M | 100.0% | Unusual | SEC |